Company Number: 15087367

Analysis Date: 2025-07-29 15:23 UTC

Financial Health Assessment for TABLENETWORK LIMITED (As of 1 September 2024)

---

1. Financial Health Score: B

Explanation:
TABLENETWORK LIMITED shows a solid start-up financial position with positive net assets and no current liabilities, indicating no immediate financial distress. However, as a recently incorporated micro-entity without significant scale or operating history, it naturally carries some early-stage risks. The absence of liabilities and positive equity suggest a “healthy pulse,” but the very limited asset base and minimal working capital point to a fragile financial state typical of new ventures.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	1,460	Represents initial investment in long-term assets (likely equipment/software). Modest but stable.
Current Assets	477	Cash or short-term assets available. Low but positive, indicating some liquidity.
Current Liabilities	0	No short-term debts, which is a healthy sign—no immediate financial obligations.
Net Current Assets	477	Positive working capital, meaning the company can cover short-term commitments comfortably.
Total Net Assets	1,937	Indicates shareholder funds and company equity. Positive net worth is a fundamental health indicator.
Shareholders Funds	1,937	Equity provided by owners, matching net assets, reflecting a clean balance sheet.
Number of Employees	1	Very small workforce consistent with micro-entity status; low fixed cost base.

Additional Context:

• The company is classified as a micro-entity, which has minimal filing and reporting requirements.
• No long-term debt or provisions indicate no hidden financial strains.
• The business operates in “Other business support service activities not elsewhere classified” (SIC 82990), suggesting a consultancy or service-oriented model with likely low capital intensity.

---

3. Diagnosis: What the Financial Data Reveals

The financial “vitals” of TABLENETWORK LIMITED resemble those of a newborn patient: stable but delicate. The company’s balance sheet shows no signs of distress such as liabilities or negative working capital, which are common “symptoms” of financial trouble. The positive net assets and shareholders’ funds indicate initial funding and equity are intact, providing a buffer against early operational risks.

However, the low overall asset base and modest current assets highlight that the company is in its infancy with limited resources to absorb shocks or fund rapid growth without additional capital injections. The minimal employee headcount and simple structure align with a lean startup approach, reducing overhead but also limiting operational scale.

No red flags such as overdue filings, director disqualifications, or liquidity issues are present, which supports a clean “medical record” from a compliance and governance perspective.

---

4. Recommendations: Path to Financial Wellness

• Build Cash Reserves: Aim to increase current assets (cash or equivalents) to strengthen liquidity and provide a cushion against unforeseen expenses or delayed receivables. Healthy cash flow is vital for survival and growth.

• Monitor Working Capital Closely: As the company grows, ensure that current liabilities do not outpace current assets. Maintaining positive net current assets is critical to avoid liquidity crises.

• Plan for Growth Capital: Given the micro-entity scale, explore opportunities for equity investment or external funding to finance expansion, marketing, or product development, as organic cash generation may be limited initially.

• Maintain Strong Compliance: Continue timely filing of accounts and confirmation statements to avoid penalties or regulatory issues that could cause operational “infections.”

• Focus on Profitability: Track profit and loss closely beyond just balance sheet metrics. Profitability will provide a sustainable financial foundation and prevent over-reliance on external funds.

• Risk Management: Identify key business risks and establish basic controls to protect assets and cash flow, ensuring the company’s financial “immune system” is robust.

---